Takeda Canada Inks Contract With Canadian Blood Services For GLASSIA

RTTNews | 602 วันที่ผ่านมา
Takeda Canada Inks Contract With Canadian Blood Services For GLASSIA

(RTTNews) - Takeda Canada Inc., the Canadian arm of Japan's Takeda Pharmaceutical Co. Ltd. (TAK) on Wednesday entered into a contract with Canadian Blood Services (CBS) for GLASSIA (alpha-1 proteinase inhibitor) resulting from CBS's request for proposal for hereditary deficiency of Alpha-1 Antitrypsin Deficiency (Alpha-1).

Glassia has been approved to be listed on the CBS Plasma Protein and Related Products (PPRP) formulary with specific criteria for reimbursement. This marks Takeda's entry into the Alpha-1 community in Canada, building on the company's commitment to developing innovative treatments for rare diseases.

Glassia is a liquid medicine for infusion containing human Alpha 1-Proteinase Inhibitor (A1-PI) also known as alpha-1 antitrypsin (A1AT), which is purified from human blood.

แท็ก : TAK TKPHF.PK
read more
Takeda Says FDA Approves EOHILIA To Treat Eosinophilic Esophagitis

Takeda Says FDA Approves EOHILIA To Treat Eosinophilic Esophagitis

Japan's Takeda Pharmaceutical Co. Ltd. (TAK) announced Monday that the U.S. Food and Drug Administration (FDA) has approved EOHILIA (budesonide oral suspension), the first and only FDA-approved oral therapy for people 11 years and older with eosinophilic esophagitis (EoE)1 It will be available in 2 mg/10 mL convenient, single-dose stick packs by the end of February.
RTTNews | 548 วันที่ผ่านมา
Takeda Says FDA Accepts BLA For ENTYVIO For Maintenance Therapy In Crohn's Disease

Takeda Says FDA Accepts BLA For ENTYVIO For Maintenance Therapy In Crohn's Disease

Takeda Pharmaceutical Co. Ltd. (TAK) announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted for review its Biologics License Application (BLA) for the investigational subcutaneous (SC) administration of ENTYVIO (vedolizumab) for maintenance therapy in adults with moderately to severely active Crohn's disease (CD) after induction therapy with ENTYVIO intravenous (IV).
RTTNews | 700 วันที่ผ่านมา
European Shares Seen Mixed As Focus Shifts To US-Russia Talks

European Shares Seen Mixed As Focus Shifts To US-Russia Talks

European stocks are seen opening on a mixed note Thursday as traders eagerly await a high-profile meeting between U.S. President Donald Trump and Russian President Vladimir Putin scheduled for Friday.
RTTNews | 25 นาทีที่ผ่านมา
European Economic News Preview: UK GDP & Foreign Trade Data Due

European Economic News Preview: UK GDP & Foreign Trade Data Due

Monthly GDP estimates and foreign trade from the UK and flash quarterly national accounts and employment from the euro area are due on Thursday. At 2.00 am ET, the Office for National Statistics releases UK GDP, industrial output and foreign trade data. The economy is forecast to grow 0.2 percent on a monthly basis in June, reversing a 0.1 percent fall in May.
RTTNews | 49 นาทีที่ผ่านมา
Yen Rises Against Majors

Yen Rises Against Majors

The Japanese yen strengthened against other major currencies in the Asian session on Thursday.
RTTNews | 59 นาทีที่ผ่านมา
Sensex, Nifty Marginally Higher Ahead Of US-Russia Talks

Sensex, Nifty Marginally Higher Ahead Of US-Russia Talks

Indian shares were marginally higher in early trade on Thursday, mirroring mostly positive cues from global markets ahead of the August 15 meeting between the U.S. President Donald Trump and his Russian counterpart Vladimir Putin.
RTTNews | 1 ชม. 40 นาทีที่ผ่านมา